| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Evp-corporate Qa/ Ra
1 company
Gregory Renard Jones last filed a Form 4 in September 2015, as Evp-corporate Qa/ Ra at CNMD. Gregory Renard Jones's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 15,465 shares of CNMD. The CNMD filings lean toward selling, a net 2,500 shares.
Gregory Renard Jones has 6 Form 4 filings on record from February 2015 to September 2015, all as Evp-corporate Qa/ Ra at Conmed (CNMD), 2015.
The 20 reported transactions were 7 option exercises, 7 tax withholdings, 3 stock awards and 2 option or other derivative awards, plus smaller numbers of other types.
Counted by filing, the open-market trades come to no purchases and 1 sale worth about $140K.
The only open-market sale was 2,500 shares of CNMD at an average $56.03 on August 11, 2015, about $140K.
Shares as reported in the last Form 4 for each company; the most recent is from September 2015. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 11, 2015 | CNMD Conmed Corp | Evp-corporate Qa/ Ra | Sell | 2,500 | $56.03 | $140,064.00 | -14.0% |